Cargando…
Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice
Lentiviral vectors are used in laboratories around the world for in vivo and ex vivo delivery of gene therapies, and increasingly clinical investigation as well as preclinical applications. The third-generation lentiviral vector system has many advantages, including high packaging capacity, stable g...
Autores principales: | Gándara, Carolina, Affleck, Valerie, Stoll, Elizabeth Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806069/ https://www.ncbi.nlm.nih.gov/pubmed/29212357 http://dx.doi.org/10.1089/hgtb.2017.098 |
Ejemplares similares
-
Optimized Transgene Delivery Using Third‐Generation Lentiviruses
por: Gill, Katherine P., et al.
Publicado: (2020) -
Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure
por: Li, Haishan, et al.
Publicado: (2020) -
Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents
por: Sanz-Nogués, Clara, et al.
Publicado: (2021) -
The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices
por: Fabio, Petrelli, et al.
Publicado: (2019) -
Food and Drink - Good Manufacturing Practice
por: Manning, Louise
Publicado: (2018)